Leonard S. Jacob, Director at ANTARES PHARMA, INC. (ATRS), bought 50,000 shares at $0.72 ($36K) on 2016-03-18, disclosed to the SEC on 2016-03-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ATRS | SELL | 2019-04-10 | $276K | — | Filing → |
| ATRS | SELL | 2017-10-11 | $932K | — | Filing → |
| ATRS | SELL | 2017-04-05 | $184K | — | Filing → |